Article
Once-daily timolol formulation OK'd
The FDA has approved a new drug application by ISTA Pharmaceuticals for the once-daily liquid formulation of timolol 0.5% as a therapy for glaucoma.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
